186
IMPACT OF CENSUS TRACT-BASED SOCIOECONOMIC STATUS ON TRENDS OF COLORECTAL CANCER INCIDENCE DIFFERED BY RACE AND ETHNICITY
Date
May 18, 2024
Tracks
Related Products
PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE U.S.
BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
USING ARTIFICIAL INTELLIGENCE AND RADIOMICS IMPROVES PREDICTION OF HCC IN CIRRHOSIS PATIENTS WITH INDETERMINATE NODULES: A MULTI-CENTER STUDY
BACKGROUND: The LI-RADS (Liver Reporting and Data Systems) was created to standardize reporting of CT/MR imaging for liver masses in cirrhosis patients at risk of hepatocellular carcinoma (HCC)…
SERUM BIOMARKER SIGNATURE IS PREDICTIVE OF THE RISK OF HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS
BACKGROUND. Several inflammatory and metabolic biomarkers have been associated with hepatocellular carcinoma (HCC) risk in phase I and II biomarker studies but not in longitudinal studies…